Andrew S Barbas
Overview
Explore the profile of Andrew S Barbas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel M, Shankar S, Tejedor M, Barbas A, Kim J, Mao S, et al.
Liver Transpl
. 2025 Mar;
PMID: 40062745
The 2024 Annual Congress of the International Liver Transplantation Society (ILTS) was from May 1-4th in Houston, Texas, USA, under the theme "Liver Disease and Transplantation: Breaking Barriers and Exploring...
2.
Rosales A, Blondel L, Hull J, Gao Q, Aykun N, Peek J, et al.
Nat Biomed Eng
. 2025 Feb;
PMID: 39910375
The difficulty of delivering genes to the kidney has limited the translation of genetic medicines, particularly for the more than 10% of the global population with chronic kidney disease. Here...
3.
Gao Q, Alderete I, Aykun N, Samy K, Nauser C, Raigani S, et al.
Liver Transpl
. 2024 Dec;
PMID: 39723976
Normothermic machine perfusion (NMP) facilitates the utilization of marginal liver allografts. It remains unknown whether clinical benefits offset additional costs in the real-world setting. We performed a comparison of outcomes...
4.
Carugati M, Arif S, Yarrington M, King L, Harris M, Evans K, et al.
Transplant Direct
. 2024 Nov;
10(12):e1719.
PMID: 39553739
Background: Invasive primary surgical site infections (IP-SSI) are a severe complication of liver transplant surgery. Identification of risk factors for IP-SSI is critical to IP-SSI prevention. Methods: All adult single...
5.
Martinino A, Ladowski J, Schiliro D, Hartwig M, Moris D, Barbas A
Transplant Direct
. 2024 Sep;
10(10):e1694.
PMID: 39301557
Background: The concept of TO is expanding across various surgical disciplines to establish a standardized, comprehensive quality benchmark. Traditional metrics such as 1-y patient and graft survival have been key...
6.
Oloruntoba O, Barbas A
Liver Transpl
. 2024 Aug;
30(12):1212-1213.
PMID: 39172011
No abstract available.
7.
Oshima S, Chen W, Rege A, Barbas A, Garbarino S
Transplant Direct
. 2024 Jul;
10(8):e1688.
PMID: 39076519
No abstract available.
8.
Gao Q, Kesseli S, Gonzalez T, Zhang M, Kahan R, Krischak M, et al.
Front Transplant
. 2024 Jul;
2:1171272.
PMID: 38993865
Introduction: Recombinant adeno-associated virus (rAAV) is a novel strategy used clinically for gene delivery, but has not been characterized in the context of organ transplantation. We sought to determine the...
9.
Kahan R, Abraham N, Zhang M, Novokhatny V, Alderete I, Cray P, et al.
Transplant Direct
. 2024 Jul;
10(8):e1665.
PMID: 38988689
Background: The clinical success of liver transplantation has led to increased demand, requiring further expansion of the donor pool. Therapeutic interventions to optimize organs from donation after circulatory death (DCD)...
10.
Abraham N, Gao Q, Kahan R, Alderete I, Wang B, Howell D, et al.
Transplant Direct
. 2024 May;
10(6):e1633.
PMID: 38807861
Background: Ex vivo kidney perfusion is an evolving platform that demonstrates promise in preserving and rehabilitating the kidney grafts. Despite this, there is little consensus on the optimal perfusion conditions....